Koyfin Home > Directory > Health Care > Amicus Therapeutics > Cash Flow from Operations

Amicus Therapeutics Cash Flow from Operations Chart (FOLD)

Amicus Therapeutics annual/quarterly Cash Flow from Operations from 2006 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Cash Flow from Operations for the last 12 months ending September 09, 2018 was $-314m a 31.40% decrease of -99m year over year
  • Amicus Therapeutics Annual Cash Flow from Operations for 2017 was $-215m a 30.14% decrease of -65m from 2016
  • Amicus Therapeutics Annual Cash Flow from Operations for 2016 was $-151m a 33.48% decrease of -50m from 2015
  • Amicus Therapeutics Annual Cash Flow from Operations for 2015 was $-100m a 48.40% decrease of -48m from 2014
Other Cash Flow Metrics:
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Cash Flow from Operations Data

09/2018$-133m
06/2018$-57m
03/2018$-50m
12/2017$-74m
09/2017$-49m
06/2017$-42m
03/2017$-50m
12/2016$-32m
09/2016$-41m
06/2016$-33m

Annual FOLD Cash Flow from Operations Data

2017$-215m
2016$-151m
2015$-100m
2014$-52m
2013$-46m
2012$-34m
2011$-49m
2010$-14m
2009$-43m
2008$-37m